Company: IMNN
Filing Date: 2025-12-31
Form Type: 424B5
Source: 0001493152-25-029712
Chunk: 33

Company: Imunon, Inc.
Filing Date: 2025-12-31
Form: 424B5
Chunk 33
---
 payable upon declaration of acceleration of the maturity date, 
 if other than the principal amount;                                                        |

| ● | whether                                                                                  
 the debt securities are to be issued at any original issuance discount and the amount of 
 discount with which they may be issued;                                                  |

| ● | whether                                                                                       
 the debt securities will be issued in certificated or global form and, in such case, the      
 depositary and the terms and conditions, if any, upon which interests in such global security 
 or securities may be exchanged in whole or in part for the individual securities represented  
 thereby;                                                                                      |

| ● | provisions,                                                                                 
 if any, for defeasance in whole or in part and any addition or change to provisions related 
 to satisfaction and discharge;                                                              |

| ● | the                          
 form of the debt securities; |

| ● | the                                                                                             
 terms and conditions upon which convertible debt securities will be convertible or exchangeable 
 into securities or property of the Company or another person, if at all, and any additions      
 or changes, if any, to permit or facilitate the same;                                           |

| ● | provisions,                                                                         
 if any, granting special rights to holders upon the occurrence of specified events; |

| ● | any                                          
 restriction or condition on transferability; |

| ● | any                                                                                            
 addition or change in the provisions related to compensation and reimbursement of the trustee; |

| ● | any                                                                                             
 addition to or change in the events of default described in this prospectus or in the indenture 
 and any change in the acceleration provisions so described;                                     |

| ● | whether                                                                                        
 the debt securities will restrict our ability to pay dividends, or will require us to maintain 
 any asset ratios or reserves;                                                                  |

| ● | whether                                                           
 we will be restricted from incurring any additional indebtedness; |

| ● | any                                                                                      
 addition to or change in the covenants described in this prospectus or in the indenture, 
 including terms of any restrictive covenants; and                                        |

| ● | any                                                                    
 other terms which may modify or delete any provision of the indenture. |

We may issue debt securities that provide for an amount less than their stated principal amount to be due and payable upon declaration of acceleration of their maturity pursuant to the terms of the indenture. We will provide you with information on the U.S. federal income tax considerations and other special considerations applicable to any debt securities in the applicable prospectus supplement.

| 10 |

Conversion or Exchange Rights

We will set forth in